总时间（秒）：20.04
问答时间（秒）：18.41

Based on the provided scientific literature, I will extract and standardize the information according to the predefined JSON framework.

**Variants Include**

* Gene: a-synuclein (SNCA)
	+ variants:
		- HGVS: NM_000344.4:c.153A>T
			- cDNA Change:
				- transcript: NM_000344.4
				- ref: A
				- alt: T
				- position: 153
			- Protein Change:
				- ref: I
				- alt: M
				- position: 51
			- Description in input context: c.153A>T (p.I51M)
* Gene: tau protein (MAPT)
	+ variants:
		- HGVS: NM_020294.3:c.1992G>A
			- cDNA Change:
				- transcript: NM_020294.3
				- ref: G
				- alt: A
				- position: 1992
			- Protein Change:
				- ref: E
				- alt: K
				- position: 665
			- Description in input context: c.1992G>A (p.E665K)

**Described Disease**

* Described Disease: Familial Parkinson's disease
* MONDO: N.D.

**Experiment Method**

* Assay Method: Immunohistochemistry, biochemical assays, and ultrastructural analysis
* Material used:
	+ Material Source: Human brain tissue
	+ Material Name: Not specified
	+ Description: Not specified
* Readout type: Qualitative and quantitative
* Readout description:
	+ NM_000344.4:c.153A>T (p.I51M):
		- Conclusion: Abnormal
		- Molecular Effect: partial loss-of-function
		- Result Description: Insoluble filamentous a-syn lesions were detected in almost all brain regions examined.
	+ NM_020294.3:c.1992G>A (p.E665K):
		- Conclusion: Abnormal
		- Molecular Effect: partial loss-of-function
		- Result Description: Significant accumulations of filamentous insoluble tau protein were detected in some brain regions.

**Biological and technical replicates**

* Biological replicates: Yes
* Technical replicates: Yes

**Control settings**

* Basic positive control: N.D.
* Basic negative control: N.D.

**Validation controls P/LP and B/LB**

* Validation controls P/LP: No information available
* Validation controls B/LB: No information available

**Statistical analysis method**

* Statistical analysis method: Not specified

**Threshold for normal and abnormal readout**

* Threshold for normal readout: N.D.
* Threshold for abnormal readout: N.D.

**Approved assay**

* Approved assay: Yes, as these experimental methods are generally used for studying familial Parkinson's disease.

Here is the final JSON output:

```
{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000344.4:c.153A>T",
          "cDNA Change": {
            "transcript": "NM_000344.4",
            "ref": "A",
            "alt": "T",
            "position": "153"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "M",
            "position": "51"
          },
          "Description in input context": "c.153A>T (p.I51M)"
        }
      ]
    },
    {
      "Gene": "MAPT",
      "variants": [
        {
          "HGVS": "NM_020294.3:c.1992G>A",
          "cDNA Change": {
            "transcript": "NM_020294.3",
            "ref": "G",
            "alt": "A",
            "position": "1992"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "665"
          },
          "Description in input context": "c.1992G>A (p.E665K)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Familial Parkinson's disease",
    "MONDO": "N.D."
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunohistochemistry, biochemical assays, and ultrastructural analysis",
      "Material used": {
        "Material Source": "Human brain tissue",
        "Material Name": "Not specified",
        "Description": "Not specified"
      },
      "Readout type": "Qualitative and quantitative",
      "Readout description": [
        {
          "Variant": "NM_000344.4:c.153A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Insoluble filamentous a-syn lesions were detected in almost all brain regions examined."
        },
        {
          "Variant": "NM_020294.3:c.1992G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Significant accumulations of filamentous insoluble tau protein were detected in some brain regions."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes"
      },
      "Technical replicates": {
        "Technical replicates": "Yes"
      },
      "Basic positive control": {
        "Basic positive control": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No information available"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No information available"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}
```